Bank Of Hawaii Novartis Ag Transaction History

Bank Of Hawaii

$2.38 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$80.52 - $93.75 $6,361 - $7,406	79 Added 1.94%	4,152 $351,000
Q1 2022 May 13, 2022	BUY	$80.11 - $90.62 $49,988 - $56,546	624 Added 18.09%	4,073 $357,000
Q4 2021 Feb 11, 2022	SELL	$79.7 - $88.13 $11,476 - $12,690	-144 Reduced 4.01%	3,449 $302,000
Q3 2021 Nov 08, 2021	SELL	$81.78 - $95.14 $81,943 - $95,330	-1,002 Reduced 21.81%	3,593 $294,000
Q2 2021 Jul 22, 2021	SELL	$85.24 - $94.15 $84,728 - $93,585	-994 Reduced 17.78%	4,595 $419,000
Q1 2021 May 13, 2021	BUY	$83.5 - $98.47 $47,595 - $56,127	570 Added 11.36%	5,589 $478,000
Q4 2020 Feb 10, 2021	BUY	$78.07 - $94.43 $76,508 - $92,541	980 Added 24.26%	5,019 $474,000
Q3 2020 Nov 13, 2020	BUY	$82.14 - $91.0 $331,763 - $367,549	4,039 New	4,039 $351,000
Q2 2019 Aug 15, 2019	SELL	$75.4 - $92.8 $234,795 - $288,979	-3,114 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$75.32 - $86.15 $65,001 - $74,347	-863 Reduced 21.7%	3,114 $299,000
Q4 2018 Feb 13, 2019	SELL	$73.66 - $82.02 $327,860 - $365,071	-4,451 Reduced 52.81%	3,977 $341,000
Q3 2018 Nov 09, 2018	SELL	$66.94 - $77.43 $98,468 - $113,899	-1,471 Reduced 14.86%	8,428 $726,000
Q2 2018 Aug 06, 2018	SELL	$64.91 - $73.36 $316,046 - $357,189	-4,869 Reduced 32.97%	9,899 $748,000
Q1 2018 May 04, 2018	SELL	$70.39 - $84.15 $155,421 - $185,803	-2,208 Reduced 13.01%	14,768 $1.19 Million
Q4 2017 Feb 12, 2018	SELL	$72.33 - $77.64 $22,132 - $23,757	-306 Reduced 1.77%	16,976 $1.43 Million
Q3 2017 Nov 03, 2017	SELL	$74.14 - $77.27 $570,803 - $594,901	-7,699 Reduced 30.82%	17,282 $1.48 Million
Q2 2017 Aug 14, 2017	BUY	N/A	24,981	24,981 $2.09 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $216B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Hawaii, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Hawaii with notifications on news.

Account